Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Abbott Laboratories : HOSTS CONFERENCE CALL FOR THIRD-QUARTER EARNINGS

share with twitter share with LinkedIn share with facebook
09/22/2020 | 09:28am EDT

ABBOTT PARK - Abbott (NYSE: ABT) will announce its third-quarter 2020 financial results on Wednesday, Oct. 21, 2020, before the market opens.

The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern), and will be accessible through Abbott's Investor Relations website at www.abbottinvestor.com. An archived edition of the call will be available later that day.

About Abbott

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 107,000 colleagues serve people in more than 160 countries.

Contact:

Kate Dyer

Tel: (224) 430-2121

(C) 2020 Electronic News Publishing, source ENP Newswire


share with twitter share with LinkedIn share with facebook
All news about ABBOTT LABORATORIES
09:17aABBOTT LABORATORIES : Reports third-quarter 2020 results, achieves strong double..
AQ
10/21ABBOTT LABORATORIES : Raises 2020 Earnings Guidance
DJ
10/21ABBOTT LABORATORIES : 3Q Profit, Sales Rise on Covid-19 Testing
DJ
10/21Abbott says COVID-19 test demand to grow in 2021
RE
10/21ABBOTT : 3Q Earnings Snapshot
AQ
10/21ABBOTT LABORATORIES : Results of Operations and Financial Condition, Financial S..
AQ
10/21Abbott quarterly profit rises 28.3% on strong sales of COVID-19 tests
RE
10/21ABBOTT : Reports Third-Quarter 2020 Results; Achieves Strong Double-Digit Earnin..
PR
10/20ABBOTT LABORATORIES : - improved mental and physical condition is directly linke..
AQ
10/20CYBERTHEFT LAWSUIT : ERISA Fiduciary Breach Claims Dismissed Against Plan Sponso..
AQ
More news
Financials (USD)
Sales 2020 33 554 M - -
Net income 2020 4 483 M - -
Net Debt 2020 11 202 M - -
P/E ratio 2020 43,7x
Yield 2020 1,37%
Capitalization 188 B 188 B -
EV / Sales 2020 5,92x
EV / Sales 2021 5,12x
Nbr of Employees 107 000
Free-Float 88,8%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 118,61 $
Last Close Price 105,93 $
Spread / Highest target 28,4%
Spread / Average Target 12,0%
Spread / Lowest Target -22,6%
EPS Revisions
Managers
NameTitle
Robert B. Ford President, CEO, Chief Operating Officer & Director
Miles D. White Executive Chairman
Robert E. Funck Chief Financial Officer & Executive Vice President
Roxanne Schuh Austin Independent Director
Samuel C. Scott Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES24.69%187 552
MEDTRONIC PLC-3.72%146 850
BECTON, DICKINSON AND COMPANY-13.08%68 525
HOYA CORPORATION16.94%43 777
BAXTER INTERNATIONAL INC.-2.25%41 379
DEXCOM, INC.77.31%37 133